# A Study of LY3323795 in Healthy Participants

> **NCT02989389** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 42 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3323795
- **DRUG:** Itraconazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02989389
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-12
- **Primary completion:** 2017-07-21
- **Final completion:** 2017-07-21
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2020-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02989389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02989389, "A Study of LY3323795 in Healthy Participants". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT02989389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*